| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31722-300-32 | 31722-300 | HUMAN PRESCRIPTION DRUG | Eltrombopag | Eltrombopag olamine | POWDER, FOR SUSPENSION | ORAL | 20250513 | N/A | ANDA | ANDA216620 | Camber Pharmaceuticals, Inc. | ELTROMBOPAG OLAMINE | 12.5 mg/1 | 1 CARTON in 1 KIT (31722-300-32) / 30 PACKET in 1 CARTON (31722-300-31) / 1 POWDER, FOR SUSPENSION in 1 PACKET (31722-300-12) |
| 31722-301-32 | 31722-301 | HUMAN PRESCRIPTION DRUG | Eltrombopag | Eltrombopag olamine | POWDER, FOR SUSPENSION | ORAL | 20250513 | N/A | ANDA | ANDA216620 | Camber Pharmaceuticals, Inc. | ELTROMBOPAG OLAMINE | 25 mg/1 | 1 CARTON in 1 KIT (31722-301-32) / 30 PACKET in 1 CARTON (31722-301-31) / 1 POWDER, FOR SUSPENSION in 1 PACKET (31722-301-25) |